FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Screening for bovine papillomavirus type 13 (BPV13) in a Eur...
Equine veterinary journal2021; 54(4); 662-669; doi: 10.1111/evj.13501

Screening for bovine papillomavirus type 13 (BPV13) in a European population of sarcoid-bearing equids.

Abstract: Bovine papillomavirus types 1 and 2 (BPV1 and BPV2) are accepted aetiological agents of equine sarcoids. Recently, genetically similar BPV13 has been identified from equine sarcoids in Brazil. Objective: To determine whether BPV13 DNA can be also found in sarcoid-affected horses in Austria, and donkeys in Northern Italy and the UK, and should hence be considered in the context of vaccine-mediated sarcoid prevention. Methods: Cross sectional study. Methods: A total of 194 archival, equine and asinine DNA isolates derived from confirmedly delta-BPV-positive tumours were subjected to quality control by photometric analysis and equine beta-actin PCR. Isolates with DNA concentrations >0.9 ng/µl and confirmed PCR-compatibility (n = 135) were subsequently screened for the presence of BPV13 DNA using BPV13-specific PCR primers for amplification of a 771 bp region comprising the BPV13 E5 gene. Results: BPV13 E5 PCR scored negative for all 135 samples. Included positive, negative and no-template controls yielded anticipated results, thus confirming reliability of obtained data. Conclusions: Moderate number of tested tumour DNA extracts (n = 135; equivalent to 127 tumour-affected equids). Conclusions: Despite its moderate size, the sample was considered representative enough to suggest a low occurrence of BPV13 in Austria, as it randomly comprised equine patients of different breed, age, gender, and European provenience. BPV13 was not associated with tested sarcoids in rescued donkeys originating from several other European countries. Large-scale BPV13 screenings are necessary to allow for a more precise estimation of the prevalence and distribution of BPV13 infections in European equids suffering from sarcoid disease.
© 2021 The Authors. Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2021-08-30 PubMed ID: 34459020PubMed Central: PMC9292424DOI: 10.1111/evj.13501Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the presence of Bovine papillomavirus type 13 (BPV13) in a European population of horse and donkey sarcoids. The study concluded that BPV13 was not present in any of the tested samples, suggesting a low occurrence in Austria, and among rescued donkeys from several other European countries.

Research Objectives and Methods

The research focused on determining whether DNA belonging to BPV13 was present in horse and donkey sarcoid patients in Austria, Northern Italy, and the UK. This would be important in understanding whether BPV13 should be considered a factor in the development of vaccines to prevent sarcoids.

  • Researchers conducted cross-sectional study, using a total of 194 DNA isolates extracted from tumors definitively positive for delta-BPV.
  • These isolates were first subjected to quality control using a method called photometric analysis and equine beta-actin PCR.
  • Out of these, 135 isolates that had DNA concentration greater than 0.9 ng/µl and had confirmed PCR-compatibility were selected for the main component of the research.
  • A specific technique was used to detect the presence of BPV13 DNA in these 135 samples.

Findings of the Study

The research yielded negative results for the presence of BPV13 in all 135 tested samples. This conclusion was based on:

  • The use of a specific PCR primers for amplification of a region of the BPV13 E5 gene which was used to determine the presence of BPV13.
  • Positive, negative, and no-template controls used in the experiment gave the expected outcomes, supporting the reliability of the data.

Conclusions and Recommendations

Despite the moderate sample size, the research concluded that:

  • There could be a low occurrence of BPV13 in Austria among different horse breeds, ages, genders, and provenience, based on the random selection of samples.
  • BPV13 was not associated with the tested sarcoids in rescued donkeys originating from a number of European countries.
  • The researchers, however, recommended larger scale BPV13 screenings to provide a more accurate estimation of its prevalence and distribution among European equids suffering from sarcoid disease.

Cite This Article

APA
Jindra C, Kamjunke AK, Jones S, Brandt S. (2021). Screening for bovine papillomavirus type 13 (BPV13) in a European population of sarcoid-bearing equids. Equine Vet J, 54(4), 662-669. https://doi.org/10.1111/evj.13501

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 54
Issue: 4
Pages: 662-669

Researcher Affiliations

Jindra, Christoph
  • Research Group Oncology (RGO), Clinical Unit of Equine Surgery, University Clinic for Horses, University of Veterinary Medicine, Vienna, Austria.
Kamjunke, Ann-Kristin
  • Research Group Oncology (RGO), Clinical Unit of Equine Surgery, University Clinic for Horses, University of Veterinary Medicine, Vienna, Austria.
Jones, Sarah
  • School of Veterinary Medicine, University of Glasgow, Scotland, UK.
Brandt, Sabine
  • Research Group Oncology (RGO), Clinical Unit of Equine Surgery, University Clinic for Horses, University of Veterinary Medicine, Vienna, Austria.

Conflict of Interest Statement

No competing interests have been declared.

References

This article includes 33 references
  1. Chambers G, Ellsmore VA, O'Brien PM, Reid SWJ, Love S, Campo MS, Nasir L. Association of bovine papillomavirus with the equine sarcoid.. J Gen Virol 2003 May;84(Pt 5):1055-1062.
    pubmed: 12692268doi: 10.1099/vir.0.18947-0google scholar: lookup
  2. Campo MS. Bovine papillomavirus: old system, new lessons?. In: Campo MS, editor. Papillomavirus Research: From Natural History to Vaccines and Beyond. Norfolk, UK: Caister Academic Press; 2006. p. 373–87.
  3. Hainisch EK, Brandt S. Equine sarcoids. In Robinson NE, Sprayberry KA, editors. Robinson's Current Therapy in Equine Medicine, Chapter 99. St. Louis, MO: Saunders Elsevier; 2015;424–7.
  4. Doorbar J. The papillomavirus life cycle.. J Clin Virol 2005 Mar;32 Suppl 1:S7-15.
    pubmed: 15753007doi: 10.1016/j.jcv.2004.12.006google scholar: lookup
  5. Amtmann E, Müller H, Sauer G. Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA.. J Virol 1980 Sep;35(3):962-4.
    pmc: PMC288890pubmed: 6252350doi: 10.1128/jvi.35.3.962-964.1980google scholar: lookup
  6. Bogaert L, Martens A, Van Poucke M, Ducatelle R, De Cock H, Dewulf J, De Baere C, Peelman L, Gasthuys F. High prevalence of bovine papillomaviral DNA in the normal skin of equine sarcoid-affected and healthy horses.. Vet Microbiol 2008 May 25;129(1-2):58-68.
    pubmed: 18093754doi: 10.1016/j.vetmic.2007.11.008google scholar: lookup
  7. Brandt S, Haralambus R, Shafti-Keramat S, Steinborn R, Stanek C, Kirnbauer R. A subset of equine sarcoids harbours BPV-1 DNA in a complex with L1 major capsid protein.. Virology 2008 Jun 5;375(2):433-41.
    pubmed: 18395238doi: 10.1016/j.virol.2008.02.014google scholar: lookup
  8. Carr EA, Théon AP, Madewell BR, Griffey SM, Hitchcock ME. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States.. Am J Vet Res 2001 May;62(5):741-4.
    pubmed: 11341396doi: 10.2460/ajvr.2001.62.741google scholar: lookup
  9. Tarwid JN, Fretz PB, Clark EG. Equine sarcoids: a study with emphasis on pathological diagnosis. Compend Contin Educ Pract Vet 1985;7:293–300.
  10. Knottenbelt DC, Edwards SRE, Daniel EA. The diagnosis and treatment of the equine sarcoid. Practice 1995;17:123–9.
  11. Chow LT, Broker TR. Mechanisms and regulation of papillomavirus DNA replication. In: Campo MS, editor. Papillomavirus Research: From Natural History to Vaccines and Beyond. Norfolk, UK: Caister Academic Press; 2006. p. 53–71.
  12. Lunardi M, Alfieri AA, Otonel RA, de Alcântara BK, Rodrigues WB, de Miranda AB, Alfieri AF. Genetic characterization of a novel bovine papillomavirus member of the Deltapapillomavirus genus.. Vet Microbiol 2013 Feb 22;162(1):207-13.
    pubmed: 22999523doi: 10.1016/j.vetmic.2012.08.030google scholar: lookup
  13. Narechania A, Terai M, Chen Z, DeSalle R, Burk RD. Lack of the canonical pRB-binding domain in the E7 ORF of artiodactyl papillomaviruses is associated with the development of fibropapillomas.. J Gen Virol 2004 May;85(Pt 5):1243-1250.
    pubmed: 15105541doi: 10.1099/vir.0.19765-0google scholar: lookup
  14. Nasir L, Reid SWJ. Bovine papillomaviruses and equine sarcoids. In: Campo MS, editor. Papillomavirus Research: From Natural History to Vaccines and Beyond. Norfolk, UK: Caister Academic Press; 2006. p. 389–97.
  15. Lunardi M, de Alcântara BK, Otonel RA, Rodrigues WB, Alfieri AF, Alfieri AA. Bovine papillomavirus type 13 DNA in equine sarcoids.. J Clin Microbiol 2013 Jul;51(7):2167-71.
    pmc: PMC3697707pubmed: 23637294doi: 10.1128/jcm.00371-13google scholar: lookup
  16. Roperto S, Russo V, Esposito I, Ceccarelli DM, Paciello O, Avallone L, Capparelli R, Roperto F. Mincle, an Innate Immune Receptor, Is Expressed in Urothelial Cancer Cells of Papillomavirus-Associated Urothelial Tumors of Cattle.. PLoS One 2015;10(10):e0141624.
    pmc: PMC4626233pubmed: 26513724doi: 10.1371/journal.pone.0141624google scholar: lookup
  17. Roperto S, Russo V, Leonardi L, Martano M, Corrado F, Riccardi MG, Roperto F. Bovine Papillomavirus Type 13 Expression in the Urothelial Bladder Tumours of Cattle.. Transbound Emerg Dis 2016 Dec;63(6):628-634.
    pubmed: 25597262doi: 10.1111/tbed.12322google scholar: lookup
  18. Roperto S, Russo V, Corrado F, Munday JS, De Falco F, Roperto F. Detection of bovine Deltapapillomavirus DNA in peripheral blood of healthy sheep (Ovis aries).. Transbound Emerg Dis 2018 Jun;65(3):758-764.
    pubmed: 29330926doi: 10.1111/tbed.12800google scholar: lookup
  19. Hamad MA, Al-Shammari AM, Odisho SM, Yaseen NY. Molecular Epidemiology of Bovine Papillomatosis and Identification of Three Genotypes in Central Iraq.. Intervirology 2017;60(4):156-164.
    pubmed: 29428951doi: 10.1159/000486594google scholar: lookup
  20. Hainisch EK, Abel H, Harnacker J, Wetzig M, Shafti‐Keramat S. BPV1 L1 VLP vaccination shows high potential to protect horses from equine sarcoids. In ECVS 24th Annual Scientific Meeting. 2015, European College of Veterinary Surgeons (ECVS): Berlin, Germany.
  21. Hainisch EK, Abel-Reichwald H, Shafti-Keramat S, Pratscher B, Corteggio A, Borzacchiello G, Wetzig M, Jindra C, Tichy A, Kirnbauer R, Brandt S. Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.. J Gen Virol 2017 Feb;98(2):230-241.
    pubmed: 28284277doi: 10.1099/jgv.0.000673google scholar: lookup
  22. Hainisch EK, Brandt S, Shafti-Keramat S, Van den Hoven R, Kirnbauer R. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.. Equine Vet J 2012 Jan;44(1):107-11.
    pmc: PMC3939654pubmed: 21895749doi: 10.1111/j.2042-3306.2011.00390.xgoogle scholar: lookup
  23. Harnacker J, Hainisch EK, Shafti-Keramat S, Kirnbauer R, Brandt S. Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.. J Gen Virol 2017 Jun;98(6):1329-1333.
    pubmed: 28635592doi: 10.1099/jgv.0.000791google scholar: lookup
  24. Shafti-Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, Brandt S, Kirnbauer R. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes.. Virology 2009 Oct 10;393(1):1-6.
    pmc: PMC3792341pubmed: 19729180doi: 10.1016/j.virol.2009.07.036google scholar: lookup
  25. Pratscher B, Hainisch EK, Sykora S, Brandt S, Jindra C. No evidence of bovine papillomavirus type 1 or 2 infection in healthy equids.. Equine Vet J 2019 Sep;51(5):612-616.
    pubmed: 30560998doi: 10.1111/evj.13061google scholar: lookup
  26. Abel-Reichwald H, Hainisch EK, Zahalka S, Corteggio A, Borzacchiello G, Massa B, Merlone L, Nasir L, Burden F, Brandt S. Epidemiologic analysis of a sarcoid outbreak involving 12 of 111 donkeys in Northern Italy.. Vet Microbiol 2016 Nov 30;196:85-92.
    pubmed: 27939161doi: 10.1016/j.vetmic.2016.10.021google scholar: lookup
  27. Brandt S, Haralambus R, Schoster A, Kirnbauer R, Stanek C. Peripheral blood mononuclear cells represent a reservoir of bovine papillomavirus DNA in sarcoid-affected equines.. J Gen Virol 2008 Jun;89(Pt 6):1390-1395.
    pubmed: 18474554doi: 10.1099/vir.0.83568-0google scholar: lookup
  28. Sullins KE. Equine sarcoid. Equine Practice 1986;8:21–7.
  29. Knottenbelt DC. The Equine Sarcoid: Why Are There so Many Treatment Options?. Vet Clin North Am Equine Pract 2019 Aug;35(2):243-262.
    pubmed: 31097356doi: 10.1016/j.cveq.2019.03.006google scholar: lookup
  30. Jindra C, Hainisch EK, Ruemmele A, Hofer M, Wolschek M, Brandt S. Getting rid of sarcoids – Recombinant live‐attenuated influenza viruses expressing BPV‐1 E6 and E7 as novel therapeutic vaccine for horses. In 5th Workshop on Emerging Issues in Oncogenic Virus Research. 2018. San Pietro in Bevagna.
  31. Chambers G, Ellsmore VA, O'Brien PM, Reid SW, Love S, Campo MS, Nasir L. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids.. Virus Res 2003 Oct;96(1-2):141-5.
    pubmed: 12951274doi: 10.1016/s0168-1702(03)00175-8google scholar: lookup
  32. Trewby H, Ayele G, Borzacchiello G, Brandt S, Campo MS, Del Fava C, Marais J, Leonardi L, Vanselow B, Biek R, Nasir L. Analysis of the long control region of bovine papillomavirus type 1 associated with sarcoids in equine hosts indicates multiple cross-species transmission events and phylogeographical structure.. J Gen Virol 2014 Dec;95(Pt 12):2748-2756.
    pmc: PMC4233631pubmed: 25185436doi: 10.1099/vir.0.066589-0google scholar: lookup
  33. Koch C, Ramsauer AS, Drögemüller M, Ackermann M, Gerber V, Tobler K. Genomic comparison of bovine papillomavirus 1 isolates from bovine, equine and asinine lesional tissue samples.. Virus Res 2018 Jan 15;244:6-12.
    pubmed: 29113823doi: 10.1016/j.virusres.2017.11.005google scholar: lookup

Citations

This article has been cited 5 times.
  1. Jindra C, Hainisch EK, Brandt S. Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines. Vaccines (Basel) 2023 Mar 30;11(4).
    doi: 10.3390/vaccines11040769pubmed: 37112681google scholar: lookup
  2. Munday JS, Orbell G, Fairley RA, Hardcastle M, Vaatstra B. Evidence from a Series of 104 Equine Sarcoids Suggests That Most Sarcoids in New Zealand Are Caused by Bovine Papillomavirus Type 2, although Both BPV1 and BPV2 DNA Are Detectable in around 10% of Sarcoids. Animals (Basel) 2021 Oct 29;11(11).
    doi: 10.3390/ani11113093pubmed: 34827825google scholar: lookup
  3. Cutarelli A, Buonavoglia A, Fusco G, Pellicanò R, Napoletano M, Brandt S, Roperto S. Accurate identification of bovine deltapapillomavirus in equine sarcoids by ddPCR. Sci Rep 2025 Aug 11;15(1):29414.
    doi: 10.1038/s41598-025-15353-6pubmed: 40790360google scholar: lookup
  4. De Falco F, Cutarelli A, Pellicanò R, Brandt S, Roperto S. Molecular Detection and Quantification of Ovine Papillomavirus DNA in Equine Sarcoid. Transbound Emerg Dis 2024;2024:6453158.
    doi: 10.1155/2024/6453158pubmed: 40303025google scholar: lookup
  5. Cutarelli A, De Falco F, Serpe F, Izzo S, Fusco G, Catoi C, Roperto S. Ultrasensitive detection and quantification of bovine Deltapapillomavirus in the semen of healthy horses. Sci Rep 2025 Jan 4;15(1):769.
    doi: 10.1038/s41598-024-81682-7pubmed: 39755719google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.